Neuroprotective effects of crocin against Parkinson's disease in rats: association with the mTOR signaling pathway and inhibition of ferroptosis and apoptosis
Authors:
Open Access
- 24 August 2026
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Canagliflozin attenuates Parkinson’s disease and is associated with modulation of gut-inflammasome–brain axis in ratsInflammopharmacology, 2026
- PI3K/AKT/mTOR Axis in Cancer: From Pathogenesis to TreatmentMedcomm, 2025
- Crocin Supplementation on Inflammation and Oxidative Stress: A Systematic Review and Meta‐AnalysisPhytotherapy Research, 2024
- Unraveling the AKT/ERK cascade and its role in Parkinson diseaseArchives of Toxicology, 2024
- PI3K/AKT signaling activation by roflumilast ameliorates rotenone-induced Parkinson’s disease in ratsInflammopharmacology, 2023
- The Role of Mitophagy in Various Neurological Diseases as a Therapeutic ApproachCellular and Molecular Neurobiology, 2022
- Impairment of insulin signaling pathway PI3K/Akt/mTOR and insulin resistance induced AGEs on diabetes mellitus and neurodegenerative diseases: a perspective reviewMolecular and Cellular Biochemistry, 2022
- Crocin molecular signaling pathways at a glance: A comprehensive reviewPhytotherapy Research, 2022
- Apathy and Anxiety in De Novo Parkinson's Disease Predict the Severity of Motor ComplicationsMovement Disorders Clinical Practice, 2020
- Parkinson’s disease treatment: past, present, and futureJournal of Neural Transmission, 2020